Examining the Acceptability of Helminth Education Packages "Magic Glasses Lower Mekong" and "Magic Glasses Opisthorchiasis" and Their Impact on Knowledge, Attitudes, and Practices Among Schoolchildren in the Lower Mekong Basin: Protocol for a Cluster Randomized Controlled Trial.


Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 11 12 2023
accepted: 17 04 2024
revised: 27 03 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

Helminths are a major global health issue, impacting health, educational, and socioeconomic outcomes. Infections, often starting in childhood, are linked to anemia, malnutrition, cognitive deficit, and in chronic cases of Opisthorchis viverrini (OV), cholangiocarcinoma. The main control strategy for helminth infection is mass drug administration; however, this does not prevent reinfection. As such, prevention strategies are needed. The "Magic Glasses" is a school-based cartoon health education package that has demonstrated success in improving knowledge, attitudes, and practices (KAP) surrounding soil-transmitted helminths (STH) in China and the Philippines. This study is designed to assess the acceptability and impact of the 2 new versions of the Magic Glasses targeting STH and OV designed for the Lower Mekong audience in Cambodia, Lao People's Democratic Republic (PDR), and Thailand. The objective of this study is to evaluate the acceptability of the "Magic Glasses Lower Mekong" and "Magic Glasses Opisthorchiasis" education packages among schoolchildren in the Lower Mekong Basin, and the impact of these education packages on students' KAP surrounding STH and OV, respectively. Schoolchildren will be recruited into a cluster randomized controlled trial with intervention and control arms in rural schools in Cambodia, Lao PDR, and Thailand. Schoolchildren's initial acceptability of the intervention will be evaluated using an adapted questionnaire. Sustained acceptability will be assessed at 9-month follow-up through focus group discussions with students and interviews with teachers. Impact will be evaluated by KAP questionnaires on STH and OV. KAP questionnaires will be administered to children at baseline and at follow-up. Indirect impact on parents' KAP of OV and STH will be assessed through focus group discussions at follow-up. The trial is in progress in Lao PDR and Thailand and is expected to commence in Cambodia in January 2024. The results of the study are expected to be available 18 months from the start of recruitment. We hypothesize that participants enrolled in the intervention arm of the study will have higher KAP scores for STH and OV, compared with the participants in the control arm at follow-up. We expect that students will have initial and sustained acceptability of these intervention packages. This trial will examine the acceptability of the "Magic Glasses Opisthorchiasis" and "Magic Glasses Lower Mekong" interventions and provide evidence on the effectiveness of the "Magic Glasses" on KAP related to OV and STH among schoolchildren in the Lower Mekong Basin. Study results will provide insight on acceptability and impact indicators and inform a scaling up protocol for the "Magic Glasses" education packages in Cambodia, Lao PDR, and Thailand. Australian New Zealand Clinical Trials Registry ACTRN12623000271606; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385315&isReview=true. DERR1-10.2196/55290.

Sections du résumé

BACKGROUND BACKGROUND
Helminths are a major global health issue, impacting health, educational, and socioeconomic outcomes. Infections, often starting in childhood, are linked to anemia, malnutrition, cognitive deficit, and in chronic cases of Opisthorchis viverrini (OV), cholangiocarcinoma. The main control strategy for helminth infection is mass drug administration; however, this does not prevent reinfection. As such, prevention strategies are needed. The "Magic Glasses" is a school-based cartoon health education package that has demonstrated success in improving knowledge, attitudes, and practices (KAP) surrounding soil-transmitted helminths (STH) in China and the Philippines. This study is designed to assess the acceptability and impact of the 2 new versions of the Magic Glasses targeting STH and OV designed for the Lower Mekong audience in Cambodia, Lao People's Democratic Republic (PDR), and Thailand.
OBJECTIVE OBJECTIVE
The objective of this study is to evaluate the acceptability of the "Magic Glasses Lower Mekong" and "Magic Glasses Opisthorchiasis" education packages among schoolchildren in the Lower Mekong Basin, and the impact of these education packages on students' KAP surrounding STH and OV, respectively.
METHODS METHODS
Schoolchildren will be recruited into a cluster randomized controlled trial with intervention and control arms in rural schools in Cambodia, Lao PDR, and Thailand. Schoolchildren's initial acceptability of the intervention will be evaluated using an adapted questionnaire. Sustained acceptability will be assessed at 9-month follow-up through focus group discussions with students and interviews with teachers. Impact will be evaluated by KAP questionnaires on STH and OV. KAP questionnaires will be administered to children at baseline and at follow-up. Indirect impact on parents' KAP of OV and STH will be assessed through focus group discussions at follow-up.
RESULTS RESULTS
The trial is in progress in Lao PDR and Thailand and is expected to commence in Cambodia in January 2024. The results of the study are expected to be available 18 months from the start of recruitment. We hypothesize that participants enrolled in the intervention arm of the study will have higher KAP scores for STH and OV, compared with the participants in the control arm at follow-up. We expect that students will have initial and sustained acceptability of these intervention packages.
CONCLUSIONS CONCLUSIONS
This trial will examine the acceptability of the "Magic Glasses Opisthorchiasis" and "Magic Glasses Lower Mekong" interventions and provide evidence on the effectiveness of the "Magic Glasses" on KAP related to OV and STH among schoolchildren in the Lower Mekong Basin. Study results will provide insight on acceptability and impact indicators and inform a scaling up protocol for the "Magic Glasses" education packages in Cambodia, Lao PDR, and Thailand.
TRIAL REGISTRATION BACKGROUND
Australian New Zealand Clinical Trials Registry ACTRN12623000271606; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385315&isReview=true.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/55290.

Identifiants

pubmed: 39283663
pii: v13i1e55290
doi: 10.2196/55290
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e55290

Informations de copyright

©Suji Y O'Connor, Mary Lorraine Mationg, Matthew J Kelly, Gail M Williams, Archie CA Clements, Banchob Sripa, Somphou Sayasone, Virak Khieu, Kinley Wangdi, Donald E Stewart, Sirikachorn Tangkawattana, Apiporn T Suwannatrai, Vanthanom Savathdy, Visal Khieu, Peter Odermatt, Catherine A Gordon, Sangduan Wannachart, Donald P McManus, Darren J Gray. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 16.09.2024.

Auteurs

Suji Y O'Connor (SY)

National Centre for Epidemiology and Population Health, Australian National University, Acton, Australia.

Mary Lorraine Mationg (ML)

National Centre for Epidemiology and Population Health, Australian National University, Acton, Australia.
Queensland Institute of Medical Research Berghofer Institute, Herston, Australia.

Matthew J Kelly (MJ)

National Centre for Epidemiology and Population Health, Australian National University, Acton, Australia.

Gail M Williams (GM)

School of Public Health, University of Queensland, Herston, Australia.

Archie Ca Clements (AC)

Queen's University Belfast, Belfast, United Kingdom.

Banchob Sripa (B)

Department of Tropical Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Tropical Disease Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Somphou Sayasone (S)

Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Virak Khieu (V)

National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.

Kinley Wangdi (K)

HEAL Global Research Centre, Health Research Institute, Faculty of Health, University of Canberra, Bruce, Australia.

Donald E Stewart (DE)

Queensland Institute of Medical Research Berghofer Institute, Herston, Australia.
School of Medicine and Dentistry, Griffith University, Nathan, Australia.

Sirikachorn Tangkawattana (S)

Tropical Disease Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand.

Apiporn T Suwannatrai (AT)

Tropical Disease Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Vanthanom Savathdy (V)

Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Visal Khieu (V)

National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Peter Odermatt (P)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Catherine A Gordon (CA)

Queensland Institute of Medical Research Berghofer Institute, Herston, Australia.

Sangduan Wannachart (S)

Tropical Disease Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Donald P McManus (DP)

Queensland Institute of Medical Research Berghofer Institute, Herston, Australia.

Darren J Gray (DJ)

Queensland Institute of Medical Research Berghofer Institute, Herston, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH